UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Operating expenses: | ||||
| General and administrative expenses | $ 5,760 | $ 7,839 | $ 8,921 | $ 11,345 |
| Marketing expenses | 45,120 | 90,240 | ||
| Professional expenses | 108,250 | 123,119 | 108,250 | 252,119 |
| Total operating expenses | 114,010 | 176,078 | 117,171 | 353,704 |
| Loss from operations | (114,010) | (176,078) | (117,171) | (353,704) |
| Other income (expense): | ||||
| Amortization of debt discount | (10,544) | (43,347) | ||
| Change in fair value of derivative liability | 1,479,784 | 8,750,797 | ||
| Interest expense and financing costs | 101,390 | 248,166 | 199,314 | 146,693 |
| Change in fair value of marketable securities | 154 | (1,500) | 1,469 | 669 |
| Total other income (expense) | (101,544) | 1,222,574 | (200,783) | 8,560,088 |
| Income (loss) before income taxes | (215,554) | 1,046,496 | (317,954) | 8,206,384 |
| Income tax expense | ||||
| Income (loss) from continuing operations | (215,554) | 1,046,496 | (317,954) | 8,206,384 |
| Net income (loss) | (215,554) | 1,046,496 | (317,954) | 8,206,384 |
| Less: net (loss) income attributable to the noncontrolling interest | (776) | (1,728) | (1,966) | (3,828) |
| Net income (loss) attributable to GTB Technologies Inc. | $ (214,778) | $ 1,048,224 | $ (315,988) | $ 8,210,212 |
| Weighted average common shares outstanding: | ||||
| Basic | 17,016,262,779 | 15,982,171,236 | 16,915,873,944 | 15,151,113,291 |
| Diluted | 637,498,005,791 | 69,406,539,967 | 637,498,005,791 | 69,406,539,967 |
| Net loss per share: | ||||
| Basic | $ (0.00) | $ 0.00 | $ (0.00) | $ 0.00 |
| Diluted | $ (0.00) | $ 0.00 | $ (0.00) | $ 0.00 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of unrealized gain (loss) recognized in income for derivative asset (liability) after deduction of derivative liability (asset), measured at fair value using unobservable input (level 3) and still held. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|